Jhon Carlos Castaño-Osorio

Dr. Jhon Carlos Castaño-Osorio

Medicine, Quindío University, Armenia, Quindío, Colombia
orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2009 in Talanta
Verified
Journal Article
Closed access
FLFeng Liu
Feng Liu
SWSow Yin Wan
Sow Yin Wan
ZJZhangjian Jiang
Zhangjian Jiang
Sam Fong Yau LiSam Fong Yau Li
Sam Fong Yau Li
Eng Shi OngEng Shi Ong
Eng Shi Ong
JCJhon Carlos Castaño-Osorio
Jhon Carlos Castaño-Osorio

1 September 2018 in Acta Tropica
Verified
Journal Article
Closed access
GTGerman Alberto Tellez
German Alberto Tellez
JZJesica Alejandra Zapata
Jesica Alejandra Zapata
LTLily Johana Toro
Lily Johana Toro
DHDiana Carolina Henao
Diana Carolina Henao
JAJuan Pablo Bedoya Agudelo
Juan Pablo Bedoya Agudelo
JCJhon Carlos Castaño-Osorio
Jhon Carlos Castaño-Osorio

1 August 1997 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
Jorge Enrique Gomez-MarinJorge Enrique Gomez-Marin
Jorge Enrique Gomez-Marin
MMMaria Teresa Montoya-De-Londono
Maria Teresa Montoya-De-Londono
JCJhon Carlos Castaño-Osorio
Jhon Carlos Castaño-Osorio
We studied 937 pregnant women from Quindio, Colombia for the presence of specific anti-Toxoplasma gondii IgG antibodies using the indirect immunofluorescence antibody technique (IFAT-IgG). Specific anti-T. gondii IgM antibodies detected using the immunosorbent agglutination assay (ISAgA-IgM) were investigated in patients with high titers in the IFAT-IgG (dilutions ≥ 1:1,024). We used mathematical models based on the age prevalence results of the IFAT-IgG to estimate the number of seroconversions and these were compared with the results predicted by the IgM based-incidence results. We found 15 positive cases by ISAgA-IgM and we were able to follow the children of six mothers from this group in which we found one case of congenital toxoplasmosis with the development of a retinal scar despite prenatal and postnatal treatment. The estimation of new cases for the annual total of pregnancies (approximately 8,000) in the Quindio region was 30–120 according to the ISAgA-IgM results and 57–85 using mathematical models. Thus, mathematical models based on age prevalence can give useful estimations of the magnitude of the problem.

1 August 2014 in Protein Expression and Purification
Verified
Journal Article
Closed access
GTGerman Alberto Tellez
German Alberto Tellez
JCJhon Carlos Castaño-Osorio
Jhon Carlos Castaño-Osorio

1 February 2018 in Virus Research
Verified
Journal Article
Closed access
MGMaria Isabel Giraldo Giraldo
Maria Isabel Giraldo Giraldo
OVOscar Vargas-Cuartas
Oscar Vargas-Cuartas
JGJuan C. Gallego-Gomez
Juan C. Gallego-Gomez
PSPei-Yong Shi
Pei-Yong Shi
LPLeonardo Padilla
Leonardo Padilla
RRRicardo Rajsbaum
Ricardo Rajsbaum

1 January 2000 in Memórias do Instituto Oswaldo Cruz
Verified
Journal Article
Open access
PDF file
Jorge Enrique Gomez-MarinJorge Enrique Gomez-Marin
Jorge Enrique Gomez-Marin
MMMaria Teresa Montoya-De-Londoño
Maria Teresa Montoya-De-Londoño
JCJhon Carlos Castaño-Osorio
Jhon Carlos Castaño-Osorio
FHFernando Alvarado Heine
Fernando Alvarado Heine
ADAna Maria Duque
Ana Maria Duque
JPJean Michel Pinon
Jean Michel Pinon
We studied the frequency of specific anti-Toxoplasma IgM, IgA and IgE antibodies in serum of 28 immunocompetent Colombian patients, selected by ophthalmologists and with lesions that were compatible with ocular toxoplasmosis. Patients were classified in three groups: (i) group 1 consisted of ten patients with a first episode; (ii) group 2, with seven patients with a recurrence and (iii) group 3, consisted of eleven patients with chronic chorioretinal lesion without uveitis. We found that 10/28 (35%) of Colombian patients with ocular toxoplasmosis possessed at least one serological marker for Toxoplasma infection different from IgG. In group 1 (first episode), we found simultaneous presence of specific IgM plus IgA plus IgE in 1/10 (10%). In group 2 (recurrences) in 1/7 (14%) we found IgM and IgA test positives and in 1/7 (14%) we found IgM and IgE tests positives. In group 3 (toxoplasmic chorioretinal scar) the IgA serological test was positive in 2/11 (18%). These results show that serum IgM or IgA or IgE can be present during recurrences.